Adefovir-pivoxil

Adefovir pivoxil, previously called bis-POM PMEA, is an organic phosphonate that is the dipivoxil ester of adefovir. A prodrug for adefovir, an HIV-1 reverse transcriptase inhibitor, adefovir pivoxil is used to treat chronic hepatitis B viral infection. A nephrotoxic agent, a HIV-1 reverse transcriptase inhibitor and a DNA synthesis inhibitor. It is ineffective against HIV-1.

General

Type : Pro-Drug, Drug, Propionate, Purine, tert-Butyl

Chemical_Nomenclature : [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate

Canonical SMILES : CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C

InChI : InChI=1S\/C20H32N5O8P\/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25\/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)

InChIKey : WOZSCQDILHKSGG-UHFFFAOYSA-N

Other name(s) : Adefovir pivoxil  ||  Hepsera  ||  Adefovir dipivoxil  ||  Adefovir-dipivoxil  ||  GS-0840  ||  RefChem:56260  ||  bis-POM PMEA  ||  Bis(POM)-PMEA  ||  Bis(pom)PMEA  ||  Piv2PMEA  ||  CHEMBL922  ||  SCHEMBL29729  ||  SCHEMBL29372789  ||  DB00718


MW : 501.5

Formula : C20H32N5O8P

CAS_number : 142340-99-6

PubChem : 60871

UniChem : WOZSCQDILHKSGG-UHFFFAOYSA-N

Target

Structures : No structure

Families : Carb_B_Chordata

References (6)

Title : Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infection - Zhang_2019_Antiviral.Res__104693
Author(s) : Zhang H , Liu J , Zhu X , Li X , Jin W , Chen H , Wu M , Li C , Liu C , JunqiNiu , Ding Y
Ref : Antiviral Res , :104693 , 2019
Abstract :
PubMedSearch : Zhang_2019_Antiviral.Res__104693
PubMedID: 31838002

Title : The role of human carboxylesterases in drug metabolism: have we overlooked their importance? - Laizure_2013_Pharmacotherapy_33_210
Author(s) : Laizure SC , Herring V , Hu Z , Witbrodt K , Parker RB
Ref : Pharmacotherapy , 33 :210 , 2013
Abstract :
PubMedSearch : Laizure_2013_Pharmacotherapy_33_210
PubMedID: 23386599

Title : Absorption enhancement of adefovir dipivoxil by incorporating MCT and ethyl oleate complex oil phase in emulsion - Li_2010_Acta.Pharmacol.Sin_31_881
Author(s) : Li P , Yu HZ , Zhang XX , Gan L , Zhu CL , Gan Y
Ref : Acta Pharmacol Sin , 31 :881 , 2010
Abstract :
PubMedSearch : Li_2010_Acta.Pharmacol.Sin_31_881
PubMedID: 20562905

Title : Reversible inhibitory effects of saturated and unsaturated alkyl esters on the carboxylesterases activity in rat intestine - Li_2010_Lipids_45_603
Author(s) : Li P , Zhu CL , Zhang XX , Gan L , Yu HZ , Gan Y
Ref : Lipids , 45 :603 , 2010
Abstract :
PubMedSearch : Li_2010_Lipids_45_603
PubMedID: 20532832

Title : Remofovir mesylate: a prodrug of PMEA with improved liver-targeting and safety in rats and monkeys - Lin_2004_Antivir.Chem.Chemother_15_307
Author(s) : Lin CC , Yeh LT , Vitarella D , Hong Z , Erion MD
Ref : Antivir Chem Chemother , 15 :307 , 2004
Abstract :
PubMedSearch : Lin_2004_Antivir.Chem.Chemother_15_307
PubMedID: 15646644

Title : Potent differentiation-inducing properties of the antiretroviral agent 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in the rat choriocarcinoma (RCHO) tumor cell model - Hatse_1998_Biochem.Pharmacol_56_851
Author(s) : Hatse S , Naesens L , De Clercq E , Balzarini J
Ref : Biochemical Pharmacology , 56 :851 , 1998
Abstract :
PubMedSearch : Hatse_1998_Biochem.Pharmacol_56_851
PubMedID: 9774147